Lymphoma Archives

Filter by
Categories
Tags
Authors
Show all

All
Adolescent and young adult oncology
Advanced practice providers
Advocacy
Artificial intelligence (AI)
Bladder cancer
Brain tumors
Breast cancer
Cancer care delivery research
Cancer control and survivorship
ComboMATCH precision medicine trial
Comis Symposium
Community oncology
Data science
Federally-funded cancer research
Gastrointestinal cancers
Genitourinary cancers
Geriatric oncology
Group meeting
Head and neck cancer
Health equity
Imaging
In memory
Kidney cancer
Leadership
Leukemia
Lung cancer
Lymphoma
Melanoma
Membership
Mentorship
Merkel cell carcinoma
Mesothelioma
Myelodysplastic syndromes
Myeloma
myeloMATCH
NCI-MATCH precision medicine trial
Pancreatic cancer
Patient-reported outcomes
Pragmatic clinical trials
Precision medicine
PrECOG
Prevention screening and surveillance
Prostate cancer
Public-private partnerships
Real-world data
Research policy
Sarcoma
Social determinants of health
Symptom science and treatment toxicity
TMIST mammography trial
Tobacco cessation

January 25, 2021

Trial Spotlight: Jonathan Cohen, MD on Trial PrE0404 for Relapsed/Refractory Mantle Cell Lymphoma

This phase I/II study, led by Dr. Jonathon Cohen, is evaluating the combination of ibrutinib and the oral proteasome inhibitor ixazomib in patients with relapsed/refractory mantle cell lymphoma

November 1, 2019

Now Enrolling: EA4181 Trial For Mantle Cell Lymphoma

This new trial seeks to define the optimal upfront treatment for an aggressive form of lymphoma